Cilfa Opposition, Pi3 K Delta Inhibitors, (Ar100619 A1)
No Annotations
Alert me when there are new annotations for this document
10 similar patent oppositions
-
CILFA opposition, CERITINIB, (AR100625A1)
Countries: Argentina Date: 2017
-
CILFA opposition, osimertinib, (AR115019A2)
Countries: Argentina Date: 2021
-
CILFA opposition, cannabinoid, (AR113749A1)
Countries: Argentina Date: 2020
-
CILFA opposition, vinorelbine, (AR107829A1)
Countries: Argentina Date: 2018
-
CILFA opposition, LSD1 inhibitor, (AR107871A1)
Countries: Argentina Date: 2018
-
CILFA opposition, FXR and PPAR AGONIST, (AR103624A1)
Countries: Argentina Date: 2017
-
CILFA opposition, BACE Inhibitor (LY2886721), (AR103406A1)
Countries: Argentina Date: 2017
-
CILFA opposition, LIXISENATIDE, (AR103415A1)
Countries: Argentina Date: 2017
-
CILFA opposition, Levodopa - Carbidopa, (AR103448A1)
Countries: Argentina Date: 2017
-
CILFA opposition, AMLODIPINE, LOSARTÁN AND ROSUVASTATINA, (AR098417A1)
Countries: Argentina Date: 2017